SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-03-024908
Filing Date
2003-11-06
Accepted
2003-11-06 11:41:27
Documents
9
Period of Report
2003-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a03-4818_110q.htm 10-Q 566876
3 EX-10.1 a03-4818_1ex10d1.htm EX-10.1 62786
4 EX-10.2 a03-4818_1ex10d2.htm EX-10.2 65244
5 EX-10.3 a03-4818_1ex10d3.htm EX-10.3 51189
6 EX-10.4 a03-4818_1ex10d4.htm EX-10.4 27963
7 EX-10.5 a03-4818_1ex10d5.htm EX-10.5 41875
8 EX-31.1 a03-4818_1ex31d1.htm EX-31.1 10656
9 EX-31.2 a03-4818_1ex31d2.htm EX-31.2 10642
10 EX-32.1 a03-4818_1ex32d1.htm EX-32.1 7211
  Complete submission text file 0001104659-03-024908.txt   846937
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 03981409
SIC: 2835 In Vitro & In Vivo Diagnostic Substances